CYP2C18: the orphan in the CYP2C family
Pharmacogenomics, Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - November 4, 2022 Category: Genetics & Stem Cells Authors: Pablo Zubiaur Andrea Gaedigk Source Type: research
Pharmacogenomics of medications given via nonconventional administration routes: a scoping review
Pharmacogenomics, Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - November 3, 2022 Category: Genetics & Stem Cells Authors: Samantha Socco Dyson T Wake James C Lee Henry M Dunnenberger Source Type: research
Opportunity for pharmacogenetics testing in patients with sickle cell anemia
Pharmacogenomics, Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - November 2, 2022 Category: Genetics & Stem Cells Authors: Katherine A Gallaway Colleen Sakon Jefney Ongeri Krina S Patel Johnathan Oliver Heather Patacca Andrew RW O'Brien Todd C Skaar Emma M Tillman Source Type: research
Knowledge and attitudes of incoming pharmacy students toward pharmacogenomics and survey reliability
Pharmacogenomics, Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - October 31, 2022 Category: Genetics & Stem Cells Authors: Ya-Feng Wen Pamala A Jacobson William S Oetting Chrystian Pereira Jacob T Brown Source Type: research
Diversity of pharmacogenomic variants affecting warfarin metabolism in Sri Lankans
Pharmacogenomics, Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - October 26, 2022 Category: Genetics & Stem Cells Authors: Priyanga Ranasinghe Nirmala Sirisena Vidarsha Senadeera Gayani Anandagoda Vajira HW Dissanayake Source Type: research
The revolution of pharmaco-omics: ready to open new avenues in materializing precision medicine?
Pharmacogenomics, Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - October 26, 2022 Category: Genetics & Stem Cells Authors: Georgia Ragia Vangelis G Manolopoulos Source Type: research
Association between genetic variants and the risk of nivolumab-induced immune-related adverse events
Pharmacogenomics, Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - October 21, 2022 Category: Genetics & Stem Cells Authors: Chihiro Udagawa Mari Hara Nakano Teruhiko Yoshida Yuichiro Ohe Ken Kato Taisei Mushiroda Hitoshi Zembutsu Source Type: research
Application of pharmacogenomics in supportive oncology: a patient journey
Pharmacogenomics, Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - October 14, 2022 Category: Genetics & Stem Cells Authors: Dung G Nguyen Sarah A Morris Jai N Patel Source Type: research
Impact of CYP2C19 gene polymorphisms on warfarin dose requirement: a systematic review and meta-analysis
Pharmacogenomics, Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - October 12, 2022 Category: Genetics & Stem Cells Authors: Dongxu Wang Ling Yong Qing Zhang Hao Chen Source Type: research
Effects of SLCO1B1 on elimination and toxicities of high-dose methotrexate in pediatric acute lymphoblastic leukemia
Pharmacogenomics, Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - October 4, 2022 Category: Genetics & Stem Cells Authors: Fei-Fei Yang Tian-Lin Xue Chao Gao Ying Wu Wei Lin Jun Li Rui-Dong Zhang Hu-Yong Zheng Shu-Guang Liu Source Type: research
Pharmacogenomics in psychiatry – the challenge of cytochrome P450 enzyme phenoconversion and solutions to assist precision dosing
Pharmacogenomics, Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - September 28, 2022 Category: Genetics & Stem Cells Authors: Sam Mostafa Thomas M Polasek Chad A Bousman Daniel J M üeller Leslie J Sheffield Joel Rembach Carl MJ Kirkpatrick Source Type: research
rs144012689 is a highly specific representative marker of HLA-B*15:02 in the Chinese population
Pharmacogenomics, Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - September 28, 2022 Category: Genetics & Stem Cells Authors: Pei Xi Hao Wang Zihua Zhong Shihui Liu Jiaxuan Tang Chunli Guo Penggai Dai Source Type: research
The importance of phenoconversion when using the CYP2D6 genotype in clinical practice
Pharmacogenomics,Volume 23, Issue 14, Page 749-752, September 2022. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - September 14, 2022 Category: Genetics & Stem Cells Authors: Emily J Cicali Kristin Wiisanen Source Type: research
The importance of phenoconversion when using CYP2D6 genotype in clinical practice
Pharmacogenomics, Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - September 14, 2022 Category: Genetics & Stem Cells Authors: Emily J Cicali Kristin Wiisanen Source Type: research
Considering medication exposure in genomic association studies of cognition in psychotic disorders
Pharmacogenomics, Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - September 14, 2022 Category: Genetics & Stem Cells Authors: Seenae Eum Scot Kristian Hill Jeffrey R Bishop Source Type: research
